Cognoptix, Inc.
Non-invasive eye scanning technology to detect beta amyloid biomarkers for Alzheimer's disease diagnosis
- Sector
- Medtech
- Headquarters
- ACTON, MA
- Latest Form D
- $12.6M, Oct 2014
- Total capital
- $17.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $17.6M
- 3 Form D · last Oct 2014
- 145 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 11 pending · first 2016
- Rank in peer group#425 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$12.6M
- Private capital raisedForm D · SEC · 2nd filing$390K
- Private capital raisedForm D · SEC · 1st filing$4.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#425 · top 38%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Paul HartungResearcherExecutive Officer, DirectorLinked by 1 patent
- Christine de los ReyesDirectorNamed in SEC Form D filings
- Gerald D. CagleExecutive OfficerNamed in SEC Form D filings
- Gunnar D. WeikertDirectorNamed in SEC Form D filings
- Richard D. GillDirectorNamed in SEC Form D filings
- Tom D. TrometerExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- Werner D. SchaeferDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 13- PendingSystem And Method For Detecting Tau Protein In Ocular TissueUSPTOApplication 16321683
- PendingMethod for Measuring Fluorescence in Ocular TissueUSPTOApplication 16430145
- GrantedMethods Of Preparing Ophthalmic Formulations And Uses Of SameUSPTOUS 10,350,309
Show all 13 patent records
- System And Method For Detecting Tau Protein In Ocular TissueSep 16, 2021 · Application 16321683Pending
- Method for Measuring Fluorescence in Ocular TissueMay 7, 2020 · Application 16430145Pending
- Methods Of Preparing Ophthalmic Formulations And Uses Of SameJul 16, 2019 · US 10,350,309Granted
- Method for Measuring Fluorescence in Ocular TissueSep 29, 2016 · Application 15035549Pending
- System And Method For Detecting Amyloid ProteinsSep 27, 2016 · US 9,451,909Granted
- Methods of Preparing Ophthalmic Formulations and Uses of SameApr 30, 2015 · Application 14528077Pending
- Ocular ImagingMay 9, 2013 · Application 13732940Pending
- Methods Of Preparing Ophthalmic Formulations And Uses Of SameApplication PCTUS2014063059Pending
- Method For Measuring Fluorescence In Ocular TissueApplication PCTUS2013069598Pending
- Methods of preparing ophthalmic formulations and uses of sameApplication 61898131Pending
- System And Method For Detecting Tau Protein In Ocular TissueApplication 62369570Pending
- System And Method For Detecting Amyloid ProteinsApplication PCTUS2011047628Pending
- System And Method For Detecting Tau Protein In Ocular TissueApplication PCTUS2017044592Pending
Related companies, and why
- ENURSING, LLC.Similar federal contract value in Medtech · null in contracts
- Diopter TechnologiesSimilar federal contract value in Medtech · null in contracts
- Empirical Spine, Inc.Similar federal contract value in Medtech · null in contracts
- SynderBio Inc.Similar federal contract value in Medtech · null in contracts
- Vesper Medical, Inc.Similar federal contract value in Medtech · null in contracts
- EPIPHANY BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .